Real-world diagnosis and treatment of individuals with migraine in the United States: The Migraine Insights in Diagnosis and Treatment (MIND) study.

Over 10% of adults in the US experience migraines. This study looked at how newly diagnosed migraine patients are diagnosed and treated. Researchers analyzed data from the Optum® Market Clarity database. They focused on individuals diagnosed with migraines between July 2018 and June 2021. Participants were at least 18 years old and had continuous health insurance coverage. The study aimed to fill gaps in understanding real-world migraine management. It examined the type of migraine diagnosed and where patients received treatment. The findings highlight differences in treatment approaches among healthcare providers. They also reveal the need for better education on migraine management. Understanding these patterns can help improve care for migraine patients. Overall, this study provides valuable insights into how migraines are treated in the US today. Clinical relevance: This research highlights the need for improved education on migraine diagnosis and treatment among healthcare providers to enhance patient care and outcomes.